LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
U.S. Cyclospora Case Surge: Symptoms, Testing, and When to Get Care
CDC says cyclosporiasis cases have increased in the U.S. Prolonged watery diarrhea can last weeks, and routine stool testing may miss Cyclospora. Here’s what to ask about Cyclospora-specific testing, what results can mean, and what CDC says about treatment with TMP-SMX and key…
Hospital Price Transparency in 2026: CMS Enforcement and How to Use the Files
CMS enforcement of updated hospital price transparency requirements starts April 1, 2026. Here’s what hospitals must post, what “standard charges” mean, what they don’t tell you about your bill, and how to use the files for scheduled care.
Recalled requesón/soft ricotta: what symptoms to watch for (pregnancy & high-risk)
If you ate the recalled Clover Hill Dairy soft ricotta/requesón, CDC says listeria symptoms can start the same day or take weeks—up to 10 weeks. Pregnancy and other high-risk groups should call right away if symptoms appear.
CDC Snapshot: More Kids Get Flu Vaccines Than COVID-19—Catch Up
A CDC snapshot (as of May 23, 2026) shows many more children reported getting a seasonal flu vaccine than a 2025–26 COVID-19 vaccine. Here’s a calm, step-by-step catch-up plan and how families can use the VFC program if cost is a barrier.
FDA ODACTRA label update (06/2026): dizziness and rash warnings
On June 12, 2026, the FDA approved an ODACTRA (house dust mite) sublingual immunotherapy label update adding “dizziness” and “rash” to postmarketing adverse-reaction wording. Here’s what that means for allergy symptom monitoring, who should not use ODACTRA, and when to stop and get…
Should Adults 50+ Wait for Moderna’s mRNA Flu Shot? (mFlusiva/mRNA-1010)
FDA’s VRBPAC reviewed investigational Moderna’s mRNA flu vaccine candidate (mFlusiva/mRNA-1010) for adults 50+. The Phase 3 signal showed a relative efficacy benefit versus a standard-dose comparator, but short-term reactions were more common than in the comparator. Key uncertainties—like limited data in the frail/high-risk…
Medicaid’s 80-Hours/Month Community Engagement Rule: CMS Details
CMS issued an interim final rule for Medicaid “community engagement” (80 hours/month) that states generally must start by Jan. 1, 2027. Here’s who is subject, what can count toward the hours, which exemptions—including medical frailty—may apply, and what to do if your state…
FDA: Omnipod pod lots may under-deliver insulin—check lot & DKA signs
FDA posted a May 26, 2026 voluntary medical device correction for certain Omnipod 5, Omnipod DASH, and Omnipod Eros (insulin management system) pod lots due to a manufacturing issue that could cause insulin under-delivery. Here’s how to check your pod lot and when…
EPA’s Updated Asthma Triggers Guide for Home: Wood Smoke, Mites, Mold
EPA updated its home asthma-trigger guidance on July 6, 2026. Use this practical room-by-room routine to reduce exposure to wood smoke, dust mites, mold/moisture, pets, and irritant chemicals—plus clear danger signs for when to get emergency help.
Oral cancer screening when you feel fine: ADA’s 2026 exam and cytology
Feeling fine doesn’t rule out oral cancer risk. This explainer explains what “oral cancer screening” means during a dental visit and what the 2026 ADA living guideline says about brush cytology—especially why a negative result doesn’t replace biopsy when an abnormal area is…
CMS hospital price transparency enforcement: rural guide to the data
CMS says enforcement of updated hospital price-transparency requirements starts April 1, 2026. For rural patients, CMS’s enforcement-activity dataset can help you see where compliance reviews happened and what CMS did—but it won’t tell you your exact out-of-pocket bill.
Medicare GLP-1 Bridge: $50/month Wegovy, Zepbound, Foundayo starts July 1
Starting July 1, 2026, eligible Medicare Part D beneficiaries can access certain GLP-1 weight-loss medicines through the Medicare GLP-1 Bridge at a predictable $50/month copay, through December 31, 2027. Eligibility depends on age, BMI/health conditions, and whether someone already gets a GLP-1 through…